Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
8
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
A Privacy-Preserving OCR-LLM System for Coronary Syndrome Subtyping From Admission HPI: Multicenter Validation in China and the US
The Influence of Modifying Highly Calcified Coronary Lesions on Coronary Microcirculation
Predictive Value of NT-proBNP on MACEs After Acute Coronary Syndrome
Prasugrel Or Ticagrelor De-escalation in NSTE-ACS
Atherosclerotic Lesion Proteomics by Harvesting Angioplasty Balloons (ALPHA).
HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program
Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy
EARLY-MYO-CMR-II Registry